
Quest Diagnostics Incorporated DGX
$ 235.0
0.36%
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
111 M |
Market Cap[1] |
$ 26.1 B |
EBITDA (LTM) |
$ 2.13 B |
P/E (LTM) |
26.735062 |
P/S (LTM) |
2.385368 |
EPS (LTM) |
8.87 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Twist Bioscience Corporation
TWST
|
$ 132.75 | 0.45 % | $ 7.94 B | Nasdaq Global Select Market,SPB | ||
|
Sotera Health Company
SHC
|
$ 17.89 | 0.03 % | $ 5.08 B | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 393.44 | 2.54 % | $ 53.8 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
$ 46.13 | 0.15 % | $ 10 B | NYSE | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Trinity Biotech plc
TRIB
|
$ 8.03 | 1.26 % | $ 2.88 B | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 560.36 | 2.41 % | $ 45.1 B | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 15.65 | 0.19 % | $ 1.4 B | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 12.91 | 0.29 % | $ 544 M | Nasdaq Global Select Market,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 6.47 | 2.11 % | $ 28.6 M | Nasdaq Global Select Market | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Biomerica
BMRA
|
$ 1.85 | 3.0 % | $ 5.39 M | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 3.98 | 4.82 % | $ 369 M | Nasdaq Global Select Market,SPB | ||
|
Pacific Biosciences of California
PACB
|
$ 1.73 | 0.73 % | $ 519 M | Nasdaq Global Select Market,SPB | ||
|
Neuronetics
STIM
|
$ 1.89 | 3.45 % | $ 125 M | Nasdaq Global Select Market | ||
|
Agilent Technologies
A
|
$ 172.97 | 0.07 % | $ 49.1 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 300.15 | 0.79 % | $ 14.9 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 23.66 | 3.0 % | $ 179 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 12.9 | 6.78 % | $ 136 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 13.3 | 0.94 % | $ 886 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 0.65 | 11.61 % | $ 865 K | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 19.81 | 1.57 % | $ 610 M | Nasdaq Global Market | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 262.54 | 0.3 % | $ 40.7 B | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 317.95 | 0.09 % | $ 26.5 B | NYSE,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 99.7 | 0.03 % | $ 6.73 B | Nasdaq Global Select Market,SPB | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.